Tioconazole Explained

Verifiedfields:changed
Verifiedrevid:415485693
Iupac Name:(RS)-1-[2-[(2-Chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
Image Class:skin-invert-image
Chirality:Racemic mixture
Tradename:Vagistat-1, 1-Day
Legal Us:OTC
Routes Of Administration:Topical
Cas Number:65899-73-2
Atc Prefix:D01
Atc Suffix:AC07
Pubchem:5482
Drugbank:DB01007
Chemspiderid:5282
Unii:S57Y5X1117
Kegg:D00890
Chebi:9604
Chembl:1200438
C:16
H:13
Cl:3
N:2
O:1
S:1
Synonyms:Thioconazole

Tioconazole is an antifungal medication of the imidazole class used to treat infections caused by a fungus or yeast. It is marketed under the brand names Trosyd and Gyno-Trosyd (Pfizer, later Johnson & Johnson and now Kenvue). Tioconazole ointments serve to treat women's vaginal yeast infections.[1] They are available in one day doses, as opposed to the 7-day treatments commonly used in the past.

Tioconazole topical (skin) preparations are also available for ringworm, jock itch, athlete's foot, and tinea versicolor or "sun fungus".

Tioconazole is known to bind to tubulin and inhibit its polymerization.[2]

It was patented in 1975 and approved for medical use in 1982.[3]

__TOC__

Side effects

Side effects of vaginal tioconazole may include temporary burning itching, or irritation of the vagina. Vaginal swelling or redness, difficulty or burning during urination, headache, abdominal pain, and upper respiratory tract infection have been reported by people using tioconazole.[4] These side effects may be only temporary, and do not normally interfere with the patient's comfort enough to outweigh the result.

Synthesis

Tioconazole can be synthesized by a displacement reaction between 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanol and 2-chloro-3-(chloromethyl)thiophene.[5] [6]

Notes and References

  1. http://www.mayoclinic.com/health/drug-information/DR601345 Tioconazole
  2. Baksheeva VE, La Rocca R, Allegro D, Derviaux C, Pasquier E, Roche P, Morelli X, Devred F, Golovin AV, Tsvetkov PO . NanoDSF Screening for Anti-tubulin Agents Uncovers New Structure–Activity Insights . Journal of Medicinal Chemistry . 2025 . 10.1021/acs.jmedchem.5c01008 .
  3. Book: Fischer J, Ganellin CR . Analogue-based Drug Discovery . 2006 . John Wiley & Sons . 9783527607495 . 503 . en.
  4. Web site: VAGISTAT-1 Print Label . https://web.archive.org/web/20170301052808/http://www.accessdata.fda.gov/drugsatfda_docs/nda/97/20-676_VAGISTAT-1_PRNTLBL.PDF . dead . 1 March 2017 . Food and Drug Administration . 25 January 2021 . 6 February 1997.
  5. BE . 841309 . Gymer GE . Pfizer . 1976 .
  6. US . 4062966 . Gymer GE . Pfizer . 1977 .